Rani Therapeutics Holdings, Inc. (RANI)
$0.75-6.25%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $49M
- Beta
- 0.71
- P/E (TTM)
- -3.08
- Short % float
- 15.38%
- Days to cover
- 11.6
- SI change
- +1.9%
- 1W
- -2.60%
- 1M
- -10.71%
- vs SPY 1W
- -3.02%
- vs SPY 1M
- -12.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RANI?
- LOPJLB’s latest quantitative signal on Rani Therapeutics Holdings, Inc. (RANI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RANI in?
- Rani Therapeutics Holdings, Inc. (RANI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Rani Therapeutics Holdings, Inc. (RANI) do?
- Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing method. The company maintains a comprehensive port…